These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7779715)

  • 1. Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.
    Mirzayans R; Aubin RA; Bosnich W; Blattner WA; Paterson MC
    Br J Cancer; 1995 Jun; 71(6):1221-30. PubMed ID: 7779715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faulty DNA polymerase delta/epsilon-mediated excision repair in response to gamma radiation or ultraviolet light in p53-deficient fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.
    Mirzayans R; Enns L; Dietrich K; Barley RD; Paterson MC
    Carcinogenesis; 1996 Apr; 17(4):691-8. PubMed ID: 8625479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
    Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA
    Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the signal transduction pathway mediating gamma ray-induced inhibition of DNA synthesis in human cells: indirect evidence for involvement of calmodulin but not protein kinase C nor p53.
    Mirzayans R; Famulski KS; Enns L; Fraser M; Paterson MC
    Oncogene; 1995 Oct; 11(8):1597-605. PubMed ID: 7478584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families.
    Boyle JM; Mitchell EL; Greaves MJ; Roberts SA; Tricker K; Burt E; Varley JM; Birch JM; Scott D
    Br J Cancer; 1998 Jun; 77(12):2181-92. PubMed ID: 9649131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage.
    De Moura J; Kavalec FL; Doghman M; Rosati R; Custodio G; Lalli E; Cavallari GM; Santa Maria J; Figueiredo BC
    Int J Oncol; 2010 Apr; 36(4):983-90. PubMed ID: 20198344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations.
    Barley RD; Enns L; Paterson MC; Mirzayans R
    Oncogene; 1998 Aug; 17(5):533-43. PubMed ID: 9704919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired DNA repair capacity in skin fibroblasts from various hereditary cancer-prone syndromes.
    Abrahams PJ; Houweling A; Cornelissen-Steijger PD; Jaspers NG; Darroudi F; Meijers CM; Mullenders LH; Filon R; Arwert F; Pinedo HM; Natarajan AP; Terleth C; Van Zeeland AA; van der Eb AJ
    Mutat Res; 1998 Mar; 407(2):189-201. PubMed ID: 9637247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
    Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed chromosome changes in gamma-irradiated normal and Li-Fraumeni fibroblasts.
    Boyle JM; Spreadborough AR; Greaves MJ; Birch JM; Varley JM; Scott D
    Radiat Res; 2002 Feb; 157(2):158-65. PubMed ID: 11835679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts.
    Mirzayans R; Andrais B; Scott A; Paterson MC; Murray D
    J Cell Physiol; 2010 Apr; 223(1):57-67. PubMed ID: 20039273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition?
    Williams KJ; Boyle JM; Birch JM; Norton JD; Scott D
    Oncogene; 1997 Jan; 14(3):277-82. PubMed ID: 9018113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
    Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic response to G2-phase X irradiation in relation to DNA repair and radiosensitivity in a cancer-prone family with Li-Fraumeni syndrome.
    Parshad R; Price FM; Pirollo KF; Chang EH; Sanford KK
    Radiat Res; 1993 Nov; 136(2):236-40. PubMed ID: 8248481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No defect in G1/S cell cycle arrest in irradiated Li-Fraumeni lymphoblastoid cell lines.
    Williams KJ; Heighway J; Birch JM; Norton JD; Scott D
    Br J Cancer; 1996 Sep; 74(5):698-703. PubMed ID: 8795570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
    Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
    J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 germline mutations in Li-Fraumeni syndrome.
    Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
    Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.